These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21514343)

  • 41. Immune effector mechanisms required for protection to rabies virus.
    Xiang ZQ; Knowles BB; McCarrick JW; Ertl HC
    Virology; 1995 Dec; 214(2):398-404. PubMed ID: 8553540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-immunization and post-exposure treatment with inactivated rabies vaccine of chick embryo cell culture origin (CEC).
    Kondo A
    Dev Biol Stand; 1978; 40():147-53. PubMed ID: 98373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Oral vaccination in the control of feral rabies].
    Biocca E; Bellani L
    Parassitologia; 1988; 30(1):3-12. PubMed ID: 3268770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
    Seroka D
    Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine.
    Sikes RK; Cleary WF; Koprowski H; Wiktor TJ; Kaplan MM
    Bull World Health Organ; 1971; 45(1):1-11. PubMed ID: 5004004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination challenge studies with variants of street rabies virus isolated in Nigeria.
    Okoh AE; Umoh JU; Ezeokoli CD; Addo PB
    Vaccine; 1988 Feb; 6(1):19-24. PubMed ID: 3354253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.
    Fu ZF; Rupprecht CE; Dietzschold B; Saikumar P; Niu HS; Babka I; Wunner WH; Koprowski H
    Vaccine; 1993; 11(9):925-8. PubMed ID: 8212838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro potency tests: challenges encountered during method development.
    Yomayuza CL; Thiel HJ; König M
    Dev Biol (Basel); 2012; 134():93-100. PubMed ID: 22888600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.
    Blaney JE; Wirblich C; Papaneri AB; Johnson RF; Myers CJ; Juelich TL; Holbrook MR; Freiberg AN; Bernbaum JG; Jahrling PB; Paragas J; Schnell MJ
    J Virol; 2011 Oct; 85(20):10605-16. PubMed ID: 21849459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adaptation of a Chinese ferret badger strain of rabies virus to high-titered growth in BHK-21 cells for canine vaccine development.
    Liu Y; Zhang S; Zhang F; Hu R
    Arch Virol; 2012 Dec; 157(12):2397-403. PubMed ID: 22886183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis).
    Stading BR; Osorio JE; Velasco-Villa A; Smotherman M; Kingstad-Bakke B; Rocke TE
    Vaccine; 2016 Oct; 34(44):5352-5358. PubMed ID: 27650872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
    Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
    Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57.
    Duan Y; Gu T; Zhang X; Jiang C; Yuan R; Li Z; Wang D; Chen X; Wu C; Chen Y; Wu Y; Kong W
    Mol Immunol; 2014 Jun; 59(2):136-41. PubMed ID: 24598312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein.
    Loza-Rubio E; Rojas-Anaya E; López J; Olivera-Flores MT; Gómez-Lim M; Tapia-Pérez G
    Vaccine; 2012 Aug; 30(37):5551-6. PubMed ID: 22749836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine.
    Biswas S; Reddy GS; Srinivasan VA; Rangarajan PN
    Hum Gene Ther; 2001 Oct; 12(15):1917-22. PubMed ID: 11589833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
    Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
    Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine.
    Jas D; Coupier C; Toulemonde CE; Guigal PM; Poulet H
    Vaccine; 2012 Nov; 30(49):6991-6. PubMed ID: 23059358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.